Forough Firoozbakht, Iman Rezaeian, A. Ngom, L. Rueda
{"title":"A new compact set of biomarkers for distinguishing among ten breast cancer subtypes","authors":"Forough Firoozbakht, Iman Rezaeian, A. Ngom, L. Rueda","doi":"10.1109/BIBM.2015.7359911","DOIUrl":null,"url":null,"abstract":"World-wide, one in nine women are diagnosed with breast cancer in their lifetime and breast cancer is the second leading cause of death among women. Accurate diagnosis of the specific subtypes of this disease is vital to ensure that the patients will have the best possible response to therapy. Using the newly proposed ten subtypes of breast cancer we hypothesized that machine learning techniques would offer many benefits for selecting the most informative biomarkers. Unlike existing gene selection approaches, we use a hierarchical classification approach that selects genes and builds the classifier concurrently. Our results support that this modified approach to gene selection yields a small subset of 82 genes that can predict each of these ten subtypes with accuracies ranging from 92% to 99%.","PeriodicalId":186217,"journal":{"name":"2015 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2015-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"2015 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/BIBM.2015.7359911","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
Abstract
World-wide, one in nine women are diagnosed with breast cancer in their lifetime and breast cancer is the second leading cause of death among women. Accurate diagnosis of the specific subtypes of this disease is vital to ensure that the patients will have the best possible response to therapy. Using the newly proposed ten subtypes of breast cancer we hypothesized that machine learning techniques would offer many benefits for selecting the most informative biomarkers. Unlike existing gene selection approaches, we use a hierarchical classification approach that selects genes and builds the classifier concurrently. Our results support that this modified approach to gene selection yields a small subset of 82 genes that can predict each of these ten subtypes with accuracies ranging from 92% to 99%.